NASDAQ: TOMZ) | Norovirus Strain Shift Exposes Urgent Need for Next-Generation Disinfection" src="https://www.abnewswire.com/upload/2025/11/1762935423.jpg" alt="TOMI Environmental (NASDAQ: TOMZ) | Norovirus Strain Shift Exposes Urgent Need for Next-Generation Disinfection" width="225" height="225">

The Viral Threat Hiding in Plain Sight: Between August 2024 and July 2025, the CDC’s NoroSTAT system recorded 2,675 norovirus outbreaks across the United States. A genetic shift has emerged: the GII.17 strain has overtaken the long-dominant GII.4 lineage, now responsible for roughly 75 percent of reported cases. Health officials warn this strain replacement increases outbreak frequency and severity, as current cleaning and immunity defenses are quickly becoming outdated. Why It Matters

Norovirus remains one of the most contagious and costly viral threats, spreading rapidly in schools, nursing homes, cruise ships, and hospitals. Just a few viral particles can infect hundreds, causing closures, staffing shortages, and economic losses that ripple through communities. Traditional disinfectants often fail to reach hidden areas or destroy new viral variants, allowing persistent contamination in high-contact environments.

7 Active Stocks to Watch Today: Leap Therapeutics Inc (NASDAQ: LPTX), ENDRA Life Sciences Inc. (NASDAQ: NDRA), Opendoor Technologies (NASDAQ: OPEN), Kartoon Studios, Inc (NYSE: TOON), Quhuo Ltd (NASDAQ: QH), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) and Datavault AI Inc. (NASDAQ: DVLT) all active in intraday trading sessions.

The TOMI Advantage

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) delivers a validated defense with its SteraMist® ionized Hydrogen Peroxide (iHP®) technology—proven to kill 99.9999 percent (six-log reduction) of viruses, bacteria, and spores in seconds. The gas-like mist penetrates surfaces, air spaces, and complex equipment without leaving corrosive residues, making it ideal for classrooms, healthcare facilities, transportation systems, and hospitality settings requiring rapid re-entry and safe, residue-free disinfection.

Investor Angle Norovirus is both a public-health threat and an economic disruptor. Each outbreak drives costly shutdowns and reputational risk. TOMI’s SteraMist® platform—trusted by hospitals, government agencies, and Fortune 500 companies—offers a scalable, automation-ready clean-tech solution for evolving viral challenges.Adding to investor focus, TOMI Environmental (NASDAQ: TOMZ) is scheduled to release its Q3 2025 earnings on Friday, November 14, 2025, providing fresh insight into revenue growth, recurring-sales progress, and expanding global demand for its SteraMist® technology.With infection control, food safety, and CleanTech innovation converging, TOMI stands at the forefront of a market where science, scalability, and public-health urgency are rewriting the standards for global disinfection.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com